N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
New Approaches to Neuroblastoma Therapy Consortium
M.D. Anderson Cancer Center
Yale University
Hebei Medical University Fourth Hospital
Hubei Cancer Hospital
Memorial Sloan Kettering Cancer Center
University of Aarhus
Memorial Sloan Kettering Cancer Center
SWOG Cancer Research Network
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Second Affiliated Hospital, School of Medicine, Zhejiang University
Federal University of Minas Gerais
Fundació Sant Joan de Déu
Guangzhou University of Traditional Chinese Medicine
Jules Bordet Institute
City of Hope Medical Center
Uppsala University Hospital
Medical University of Gdansk
Eastern Cooperative Oncology Group
Philipps University Marburg
Big Ten Cancer Research Consortium
S&D Pharma SK s.r.o.
University of Kentucky
Ipsen
Celgene
Celgene
Uppsala University Hospital
St. Jude Children's Research Hospital
University of Helsinki
Shiraz University of Medical Sciences
University of Aarhus
Assistance Publique - Hôpitaux de Paris
Federal University of Minas Gerais
Tianjin Medical University Cancer Institute and Hospital
Children's Oncology Group
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
Catholic University of the Sacred Heart
Novartis
AHS Cancer Control Alberta
Johns Hopkins University
M.D. Anderson Cancer Center
Johann Wolfgang Goethe University Hospital
Royal Marsden NHS Foundation Trust
St. Jude Children's Research Hospital
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Celgene Corporation
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology